- Urinalysis is a critical diagnostic tool used to detect and monitor a variety of conditions, including urinary tract infections, kidney disease, diabetes, and liver disorders, through the analysis of urine samples
- The demand for urinalysis is growing steadily due to the rising prevalence of chronic diseases, increasing geriatric population, and growing emphasis on early diagnosis and preventive healthcare
- U.S. is expected to dominate the North America urinalysis market with largest market share of approximately 33.4%, due to its advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of innovative diagnostic technologies
- Canada is expected to be the fastest growing region in the North America urinalysis market during the forecast period due to its expanding healthcare infrastructure, increasing prevalence of chronic diseases, and rising demand for early diagnostic solutions
- Consumables segment is expected to dominate the market with a largest market share of 78.57% due to the increasing demand and frequent purchases of reagents and dipsticks by clinical and hospital laboratories. Reagents are the most common type of consumable in urinalysis, accounting for the largest share of the market. Many major providers, such as Siemens Healthcare GmBH, Abbott, and Roche, provide high-quality consumables for urinalysis testing, which is expected to boost segment growth
